Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to man...
Saved in:
Published in | Emerging microbes & infections Vol. 9; no. 1; pp. 2673 - 2684 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.01.2020
Taylor & Francis Ltd Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development. |
---|---|
AbstractList | Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development. Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development.Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of deaths worldwide. There is currently no approved vaccine to halt the spread of SARS-CoV-2 and only very few treatment options are available to manage COVID-19 patients. For development of preclinical countermeasures, reliable and well-characterized small animal disease models will be of paramount importance. Here we show that intranasal inoculation of SARS-CoV-2 into Syrian hamsters consistently caused moderate broncho-interstitial pneumonia, with high viral lung loads and extensive virus shedding, but animals only displayed transient mild disease. We determined the infectious dose 50 to be only five infectious particles, making the Syrian hamster a highly susceptible model for SARS-CoV-2 infection. Neither hamster age nor sex had any impact on the severity of disease or course of infection. Finally, prolonged viral persistence in interleukin 2 receptor gamma chain knockout hamsters revealed susceptibility of SARS-CoV-2 to adaptive immune control. In conclusion, the Syrian hamster is highly susceptible to SARS-CoV-2 making it a very suitable infection model for COVID-19 countermeasure development. |
Author | Li, Rong Jarvis, Michael A. Feldmann, Heinz Letko, Michael Feldmann, Friederike Okumura, Atsushi Hansen, Frederick Wang, Zhongde Liu, Yanan Scott, Dana Saturday, Greg Clancy, Chad Tang-Huau, Tsing-Lee Munster, Vincent Meade-White, Kimberly Rosenke, Kyle |
Author_xml | – sequence: 1 givenname: Kyle surname: Rosenke fullname: Rosenke, Kyle organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 2 givenname: Kimberly surname: Meade-White fullname: Meade-White, Kimberly organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 3 givenname: Michael surname: Letko fullname: Letko, Michael organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 4 givenname: Chad surname: Clancy fullname: Clancy, Chad organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 5 givenname: Frederick surname: Hansen fullname: Hansen, Frederick organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 6 givenname: Yanan surname: Liu fullname: Liu, Yanan organization: Utah State University – sequence: 7 givenname: Atsushi surname: Okumura fullname: Okumura, Atsushi organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 8 givenname: Tsing-Lee surname: Tang-Huau fullname: Tang-Huau, Tsing-Lee organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 9 givenname: Rong surname: Li fullname: Li, Rong organization: Utah State University – sequence: 10 givenname: Greg surname: Saturday fullname: Saturday, Greg organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 11 givenname: Friederike surname: Feldmann fullname: Feldmann, Friederike organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 12 givenname: Dana surname: Scott fullname: Scott, Dana organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 13 givenname: Zhongde surname: Wang fullname: Wang, Zhongde organization: Utah State University – sequence: 14 givenname: Vincent orcidid: 0000-0002-2288-3196 surname: Munster fullname: Munster, Vincent organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 15 givenname: Michael A. surname: Jarvis fullname: Jarvis, Michael A. organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health – sequence: 16 givenname: Heinz orcidid: 0000-0001-9448-8227 surname: Feldmann fullname: Feldmann, Heinz email: feldmannh@niaid.nih.gov organization: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33251966$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAQjVARLaU_AWSJC5cU23FiR0iIavmqVAmJBY5YE9vZeOXYWzsL2n-Pw26rtgeYi62Z957HM-9pceSDN0XxnOBzggV-TXMQXpNzimlOiVoQzh8VJ3O-nAtHd-7HxVlKa5yD44YR9qQ4ripak7ZpToqf701vvfUrNA0GLXfRgkcDjGkyEUFCgAa7GtwOpW1SZjPZzhm0iUa5zFLg0Bi0cagPES0vvi7LRfhRUmR9b9Rkg39WPO7BJXN2OE-L7x8_fFt8Lq--fLpcXFyVqqFiKjVta4FxywhoXIlGG9URUdG-w73osAHgDdMCOlbxDkzbY8UoqVummCZUm-q0uNzr6gBruYl2hLiTAaz8mwhxJSFOVjkjia6AEE4b0ub3lOqo5ox1NcfA-qoXWevtXmuz7UajlfFTBHdP9H7F20Guwi_JuaC0abLAq4NADNdbkyY52jw858CbsE2SsqbmdVtjnKEvH0DXYRt9HpWkNRZzlw3LqBd3O7pt5WaNGVDvASqGlKLpbyEEy9kx8sYxcnaMPDgm89484Ck7wby4_DHr_st-t2fndYc4wu8QnZYT7FyIfQSvbJLVvyX-ACaq14A |
CitedBy_id | crossref_primary_10_1038_s41392_022_01039_2 crossref_primary_10_1080_22221751_2021_1997074 crossref_primary_10_1371_journal_ppat_1010741 crossref_primary_10_1126_scisignal_adg5470 crossref_primary_10_1016_j_ebiom_2021_103403 crossref_primary_10_3389_fimmu_2023_941281 crossref_primary_10_2139_ssrn_3915655 crossref_primary_10_1038_s41591_022_01780_9 crossref_primary_10_1111_cbdd_13954 crossref_primary_10_3390_microorganisms10020407 crossref_primary_10_3390_ijms24065352 crossref_primary_10_3390_v14061218 crossref_primary_10_1002_mco2_98 crossref_primary_10_1002_jmv_28103 crossref_primary_10_2139_ssrn_3929650 crossref_primary_10_1172_jci_insight_159573 crossref_primary_10_1038_s41467_025_55938_3 crossref_primary_10_1038_s42003_023_04589_5 crossref_primary_10_1093_ilar_ilab007 crossref_primary_10_3390_covid2110111 crossref_primary_10_1038_s41564_021_01047_y crossref_primary_10_1016_j_coviro_2021_03_009 crossref_primary_10_3390_v13081653 crossref_primary_10_3389_fimmu_2021_788235 crossref_primary_10_1186_s13567_021_00988_w crossref_primary_10_1016_j_isci_2025_111875 crossref_primary_10_1080_20477724_2023_2228048 crossref_primary_10_1080_22221751_2023_2178242 crossref_primary_10_1126_sciimmunol_abm3131 crossref_primary_10_1111_xen_12772 crossref_primary_10_1038_s41598_022_23339_x crossref_primary_10_1080_26895293_2025_2468334 crossref_primary_10_3390_vaccines11121831 crossref_primary_10_7554_eLife_75537 crossref_primary_10_1093_cid_ciab903 crossref_primary_10_3390_v13101993 crossref_primary_10_1177_03009858211057197 crossref_primary_10_3390_v16020246 crossref_primary_10_3390_pathogens12010020 crossref_primary_10_1016_j_ebiom_2023_104597 crossref_primary_10_1128_mBio_00974_21 crossref_primary_10_1093_biosci_biad102 crossref_primary_10_3390_pathogens10070824 crossref_primary_10_1038_s41467_023_42140_6 crossref_primary_10_3389_fimmu_2022_1080897 crossref_primary_10_1038_s44298_023_00012_2 crossref_primary_10_3389_fimmu_2022_836745 crossref_primary_10_1128_jvi_01366_22 crossref_primary_10_1186_s13578_024_01280_y crossref_primary_10_1128_mBio_02527_21 crossref_primary_10_3390_v14020418 crossref_primary_10_1038_s41467_021_25156_8 crossref_primary_10_7554_eLife_73522 crossref_primary_10_3390_vaccines9040340 crossref_primary_10_1007_s00439_023_02549_x crossref_primary_10_1016_j_biochi_2021_06_005 crossref_primary_10_1002_ame2_12278 crossref_primary_10_1016_j_celrep_2022_111002 crossref_primary_10_1016_j_ebiom_2022_104203 crossref_primary_10_1111_cbdd_14035 crossref_primary_10_1128_spectrum_04998_22 crossref_primary_10_1016_j_bbi_2024_10_032 crossref_primary_10_3390_v15112151 crossref_primary_10_1016_j_antiviral_2023_105605 crossref_primary_10_1038_s41467_021_22580_8 crossref_primary_10_1096_fj_202100431R crossref_primary_10_1126_scitranslmed_abh0755 crossref_primary_10_7554_eLife_87094 crossref_primary_10_1038_s41598_021_00843_0 crossref_primary_10_1177_01926233211072767 crossref_primary_10_36233_0372_9311_528 crossref_primary_10_1016_j_virs_2022_09_008 crossref_primary_10_1038_s41421_024_00734_4 crossref_primary_10_1155_2023_1868732 crossref_primary_10_3390_v15030725 crossref_primary_10_1038_s41598_022_09218_5 crossref_primary_10_1002_jmv_70237 crossref_primary_10_3390_v17010100 crossref_primary_10_1002_advs_202202771 crossref_primary_10_1038_s41392_024_01917_x crossref_primary_10_1111_ina_13118 crossref_primary_10_1080_22221751_2021_1943539 crossref_primary_10_3389_fcimb_2022_979641 crossref_primary_10_3390_biomedicines12030642 crossref_primary_10_3390_pathogens12030364 crossref_primary_10_3390_v14030639 crossref_primary_10_30802_AALAS_CM_21_000046 crossref_primary_10_1016_j_ebiom_2025_105615 crossref_primary_10_1038_s41392_022_01087_8 crossref_primary_10_1016_j_ebiom_2021_103675 crossref_primary_10_1177_03009858211067468 crossref_primary_10_3389_fmicb_2023_1148255 crossref_primary_10_7554_eLife_87094_3 crossref_primary_10_30621_jbachs_1315023 crossref_primary_10_3389_fimmu_2023_1060540 crossref_primary_10_1371_journal_ppat_1009705 crossref_primary_10_2139_ssrn_4151032 crossref_primary_10_1038_s41556_021_00821_8 crossref_primary_10_1371_journal_ppat_1010807 crossref_primary_10_2174_2666796704666230330083413 crossref_primary_10_1016_j_coviro_2023_101375 crossref_primary_10_30802_AALAS_CM_21_000036 crossref_primary_10_1016_j_cell_2021_02_026 crossref_primary_10_1128_spectrum_01789_21 crossref_primary_10_1016_j_medj_2022_03_009 crossref_primary_10_1016_j_ajpath_2023_02_013 crossref_primary_10_1371_journal_ppat_1011298 crossref_primary_10_3390_v13122506 crossref_primary_10_3390_v15030748 crossref_primary_10_3389_fviro_2022_891540 crossref_primary_10_3389_fimmu_2023_1223260 crossref_primary_10_1177_20503121221115053 crossref_primary_10_1016_j_dib_2023_109158 crossref_primary_10_1098_rsif_2024_0009 crossref_primary_10_1080_22221751_2022_2058419 crossref_primary_10_36233_0507_4088_63 crossref_primary_10_1093_infdis_jiab289 crossref_primary_10_1371_journal_ppat_1011293 crossref_primary_10_1016_j_omtm_2023_06_009 crossref_primary_10_1016_j_vaccine_2022_03_064 crossref_primary_10_1080_21505594_2024_2316438 crossref_primary_10_3390_biomedicines10061343 crossref_primary_10_1007_s11250_023_03470_1 crossref_primary_10_1038_s43587_021_00156_x crossref_primary_10_1080_08958378_2024_2412685 crossref_primary_10_1172_jci_insight_163962 crossref_primary_10_1128_mBio_01415_21 crossref_primary_10_1016_j_isci_2022_105074 crossref_primary_10_3390_v13050815 crossref_primary_10_1172_jci_insight_160108 crossref_primary_10_3390_pathogens11101112 crossref_primary_10_3390_v13112251 crossref_primary_10_1152_ajpregu_00356_2020 crossref_primary_10_1016_j_ebiom_2022_104248 crossref_primary_10_1161_CIRCRESAHA_121_320518 crossref_primary_10_1038_s41467_023_39049_5 crossref_primary_10_1038_s44298_024_00061_1 crossref_primary_10_3389_fvets_2024_1435464 crossref_primary_10_3390_cimb45010019 crossref_primary_10_1016_j_antiviral_2022_105345 crossref_primary_10_1016_j_biopha_2022_112872 crossref_primary_10_1128_mbio_00078_23 crossref_primary_10_1038_s41598_022_19222_4 crossref_primary_10_1016_j_chom_2022_01_006 crossref_primary_10_3390_vaccines10030435 crossref_primary_10_1016_j_celrep_2022_110515 crossref_primary_10_1371_journal_pone_0257191 crossref_primary_10_3390_vaccines11121771 crossref_primary_10_3390_v15010085 |
Cites_doi | 10.3851/IMP3368 10.1101/2020.05.14.096727 10.1128/JVI.00127-20 10.1016/j.cell.2020.05.027 10.1016/j.chom.2020.03.023 10.1038/s41586-020-2342-5 10.1101/2020.06.29.177154 10.3390/ijms21082948 10.1016/S0140-6736(20)30211-7 10.1016/S2666-5247(20)30089-6 10.1101/2020.05.27.118893 10.3345/cep.2020.00493 10.1128/JVI.02012-06 10.1073/pnas.2009799117 10.1016/j.immuni.2019.03.028 10.1101/2020.05.02.073411 10.1016/j.cell.2020.06.011 10.1016/j.ijantimicag.2020.105949 10.1001/jama.2020.5394 10.1101/2020.05.06.081497 10.1242/dmm.044602 10.1038/s41564-020-0688-y 10.1093/oxfordjournals.aje.a118408 10.1038/s41586-020-2312-y 10.1126/science.abb7015 10.1126/science.abb7314 10.1038/s41586-020-2324-7 10.2807/1560-7917.ES.2020.25.3.2000045 10.1016/j.chom.2020.05.020 10.3201/eid2606.200516 10.1001/jama.2020.1585 10.1128/JVI.01702-06 10.1007/s13238-020-00767-x 10.1038/s41586-020-2012-7 10.1128/JVI.00737-08 |
ContentType | Journal Article |
Copyright | 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. . This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 The Author(s) |
Copyright_xml | – notice: 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 – notice: This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. . This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 The Author(s) |
DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1080/22221751.2020.1858177 |
DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Coronavirus Research Database ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
DocumentTitleAlternate | Emerging Microbes & Infections |
EISSN | 2222-1751 |
EndPage | 2684 |
ExternalDocumentID | oai_doaj_org_article_1d3a1172619941ccb2d744b570a4f3f8 PMC7782266 33251966 10_1080_22221751_2020_1858177 1858177 |
Genre | Research Article Journal Article |
GrantInformation_xml | – fundername: National Institutes of Allergy and Infectious Diseases (NIAID) – fundername: National Institutes of Health (NIH) – fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases funderid: 10.13039/100006492 |
GroupedDBID | 0YH 3V. 53G 5VS 7X7 88E 8FI 8FJ AAHBH ABUWG ACGFS ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVXVI C6C CCPQU DIK EBS ECGQY EMOBN FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M1P M48 M4Z M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM TDBHL UKHRP AAYXX BCNDV CITATION EJD PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC COVID DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c628t-d295800941ad0386decb1832fb0f8b0eaa764d8ab437bae9f0c421594c4d12de3 |
IEDL.DBID | M48 |
ISSN | 2222-1751 |
IngestDate | Wed Aug 27 01:26:14 EDT 2025 Thu Aug 21 13:29:59 EDT 2025 Fri Jul 11 11:32:45 EDT 2025 Fri Jul 25 20:52:50 EDT 2025 Thu Jan 02 22:56:00 EST 2025 Thu Apr 24 22:52:33 EDT 2025 Tue Jul 01 05:04:30 EDT 2025 Wed Dec 25 09:05:03 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | SARS-CoV-2 infection model pneumonia hamster susceptible |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c628t-d295800941ad0386decb1832fb0f8b0eaa764d8ab437bae9f0c421594c4d12de3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Supplemental data for this article can be accessed at https://doi.org/10.1080/22221751.2020.1858177 Current affiliation: Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA, USA. |
ORCID | 0000-0001-9448-8227 0000-0002-2288-3196 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1080/22221751.2020.1858177 |
PMID | 33251966 |
PQID | 2508726164 |
PQPubID | 2041957 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1d3a1172619941ccb2d744b570a4f3f8 crossref_primary_10_1080_22221751_2020_1858177 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7782266 crossref_citationtrail_10_1080_22221751_2020_1858177 pubmed_primary_33251966 proquest_miscellaneous_2465759500 informaworld_taylorfrancis_310_1080_22221751_2020_1858177 proquest_journals_2508726164 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | Emerging microbes & infections |
PublicationTitleAlternate | Emerg Microbes Infect |
PublicationYear | 2020 |
Publisher | Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group |
References | e_1_3_5_29_1 e_1_3_5_28_1 e_1_3_5_27_1 e_1_3_5_26_1 e_1_3_5_25_1 e_1_3_5_24_1 e_1_3_5_23_1 e_1_3_5_22_1 Conti P (e_1_3_5_38_1) 2020; 34 e_1_3_5_3_1 e_1_3_5_2_1 e_1_3_5_40_1 e_1_3_5_41_1 e_1_3_5_42_1 e_1_3_5_9_1 e_1_3_5_21_1 e_1_3_5_20_1 Allenspach E (e_1_3_5_36_1) 1993 e_1_3_5_5_1 e_1_3_5_4_1 e_1_3_5_6_1 e_1_3_5_18_1 e_1_3_5_17_1 e_1_3_5_39_1 e_1_3_5_16_1 e_1_3_5_15_1 e_1_3_5_37_1 e_1_3_5_13_1 e_1_3_5_14_1 e_1_3_5_35_1 e_1_3_5_11_1 e_1_3_5_34_1 e_1_3_5_12_1 e_1_3_5_33_1 e_1_3_5_19_1 Sanders JM (e_1_3_5_7_1) 2020; 323 Ali MJ (e_1_3_5_8_1) 2020; 7 e_1_3_5_32_1 e_1_3_5_10_1 e_1_3_5_31_1 e_1_3_5_30_1 32995767 - bioRxiv. 2020 Sep 27 |
References_xml | – ident: e_1_3_5_9_1 doi: 10.3851/IMP3368 – ident: e_1_3_5_11_1 doi: 10.1101/2020.05.14.096727 – ident: e_1_3_5_22_1 doi: 10.1128/JVI.00127-20 – ident: e_1_3_5_41_1 doi: 10.1016/j.cell.2020.05.027 – ident: e_1_3_5_13_1 doi: 10.1016/j.chom.2020.03.023 – ident: e_1_3_5_20_1 doi: 10.1038/s41586-020-2342-5 – ident: e_1_3_5_34_1 doi: 10.1101/2020.06.29.177154 – ident: e_1_3_5_37_1 doi: 10.3390/ijms21082948 – ident: e_1_3_5_4_1 doi: 10.1016/S0140-6736(20)30211-7 – ident: e_1_3_5_14_1 doi: 10.1016/S2666-5247(20)30089-6 – ident: e_1_3_5_24_1 doi: 10.1101/2020.05.27.118893 – ident: e_1_3_5_40_1 doi: 10.3345/cep.2020.00493 – ident: e_1_3_5_25_1 doi: 10.1128/JVI.02012-06 – ident: e_1_3_5_18_1 doi: 10.1073/pnas.2009799117 – ident: e_1_3_5_35_1 doi: 10.1016/j.immuni.2019.03.028 – ident: e_1_3_5_19_1 doi: 10.1101/2020.05.02.073411 – ident: e_1_3_5_23_1 doi: 10.1016/j.cell.2020.06.011 – ident: e_1_3_5_6_1 doi: 10.1016/j.ijantimicag.2020.105949 – ident: e_1_3_5_39_1 doi: 10.1001/jama.2020.5394 – ident: e_1_3_5_16_1 doi: 10.1101/2020.05.06.081497 – ident: e_1_3_5_30_1 doi: 10.1242/dmm.044602 – ident: e_1_3_5_2_1 – ident: e_1_3_5_21_1 doi: 10.1038/s41564-020-0688-y – ident: e_1_3_5_31_1 doi: 10.1093/oxfordjournals.aje.a118408 – volume: 34 issue: 2 year: 2020 ident: e_1_3_5_38_1 article-title: Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection publication-title: J Biol Regul Homeost Agents – ident: e_1_3_5_17_1 doi: 10.1038/s41586-020-2312-y – ident: e_1_3_5_15_1 doi: 10.1126/science.abb7015 – ident: e_1_3_5_12_1 doi: 10.1126/science.abb7314 – ident: e_1_3_5_10_1 doi: 10.1038/s41586-020-2324-7 – volume: 7 issue: 480 year: 2020 ident: e_1_3_5_8_1 article-title: Treatment options for COVID-19: a review publication-title: Front Med (Lausanne) – ident: e_1_3_5_3_1 – ident: e_1_3_5_32_1 doi: 10.2807/1560-7917.ES.2020.25.3.2000045 – ident: e_1_3_5_27_1 doi: 10.1016/j.chom.2020.05.020 – ident: e_1_3_5_29_1 doi: 10.3201/eid2606.200516 – ident: e_1_3_5_5_1 doi: 10.1001/jama.2020.1585 – ident: e_1_3_5_26_1 doi: 10.1128/JVI.01702-06 – ident: e_1_3_5_28_1 doi: 10.1007/s13238-020-00767-x – volume: 323 start-page: 1824 issue: 18 year: 2020 ident: e_1_3_5_7_1 article-title: Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review publication-title: JAMA – ident: e_1_3_5_33_1 doi: 10.1038/s41586-020-2012-7 – volume-title: X-linked severe combined immunodeficiency year: 1993 ident: e_1_3_5_36_1 – ident: e_1_3_5_42_1 doi: 10.1128/JVI.00737-08 – reference: 32995767 - bioRxiv. 2020 Sep 27;: |
SSID | ssj0000706414 |
Score | 2.5378768 |
Snippet | Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently responsible for millions of infections and hundreds of thousands of... |
SourceID | doaj pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2673 |
SubjectTerms | Animals Chlorocebus aethiops Coronaviruses COVID-19 COVID-19 - etiology COVID-19 - immunology COVID-19 - pathology Cricetinae Disease Models, Animal Disease Susceptibility Female hamster infection model Infections Lung - pathology Male Mesocricetus pneumonia Receptors, Interleukin-2 - physiology RNA, Viral - analysis SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - metabolism susceptible Vero Cells |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTpUq1AeFtLRyJa4pduz4cQRahCq1h26pOGH5FVFpyaLu7oF_j8dOVrsIaS9c_VA8nhnPxJ75BqEjF0QQjMXae-Fr3gRWOw21XniyL13QrqSP_fwlLi75j6v2aq3UF8SEFXjgsnHHNDBLk5UVAGJLvXdNkJy7VhLLO9blNN9k89Z-pvIZLJOppXxM2VHkONnB5H238EvYpCbVKirlhjHKmP2PEEuf8jsfh0-u2aPz12h3cCTxSSHgDXoR-7foVbmFwyW56B26_ha7XAECJz8PT-6TtPX4xt4COgK2c2wxwBVP7_F8Oc_xLW4a8V06BId8SZwL5eC0Ujw5-T2pz2Z_6waPAVz9Hro8__7n7KIeKirUXjRqUYdGtwqCCakNhCkRoneg050jnXIkWisFD8o6zqSzUXfEA8809zzQJkT2Hu30sz4eIOzTEGVb5rzSXFvmhFBUSOGUJ04yVSE-bq3xA9w4VL2YGjqgko4cMcARM3CkQl9X0-4K3sa2CafAt9VggMvODUmIzCBEZpsQVUivc90s8m1JV0qbGLZlAYejiJhB_-cmOZYKPid4hb6supPmwnOM7eNsmcZwePTSLSEV2i8StaKCMcgoFqJCckPWNsjc7On_3WR0cAk-nxAfnmNfPqKXQGq5cjpEO4v_y_gpOWEL9znr2wNbrygc priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagXJAQ4k2gICNxNU1ix48TKoWqQoIDS9GesPwKRVqSpdk99N_jcZzQrRC9xrZke54Zz3yD0GvrueeUBuIcd4TVnhKroNcLi_al9cqO5WOfPvOTU_Zx2SxzwG3IaZWTTkyK2vcOYuQH0VRLEd19zt6ufxPoGgWvq7mFxk10C6DLIKVLLMUcY4nszFnFpsIdWR5Eaxh98AZ-DOv4STayEmLHJCXk_iu4pf_yPq8mUV6ySsf30N3sTuLDkf730Y3QPUB3xlgcHkuMHqLv70Ob-kDg6O3hxUXkuQ6fmV-AkYDNgA0G0OLVBR62Q8pysauA11EV5qpJnNrl4LhTvDj8siBH_TdS4ymNq3uETo8_fD06IbmvAnG8lhvi63hVkFJYGV9SyX1wFiS7tWUrbRmMEZx5aSyjwpqg2tIB5RRzzFe1D_Qx2uv6LjxF2MUp0jTUOqmYMtRyLisuuJWutILKArHparXLoOPQ-2Klq4xNOlFEA0V0pkiB3szL1iPqxnUL3gHd5skAmp0-9Oc_dJZBXXlqqgqYSMWzO2drLxizjSgNa2kbN6suU11vUsykHRucaHrNBvYnFtFZCwz6L88W6NU8HOUXHmVMF_ptnMPg6Us1ZVmgJyNHzaegFOqKOS-Q2OG1nWPujnQ_zxJGuADPj_Nn_9_Wc3QbDjGGlPbR3uZ8G15EJ2tjXyZJ-gP0uCBX priority: 102 providerName: ProQuest – databaseName: Taylor & Francis Open Access dbid: 0YH link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagXJAQ4k2gICNxDTixM3aOpVCtkODAUgQXLL_SIi3Zqtk99N_jcZyoW4F64BjHVuzMjGc8nvmGkNfWgwfOQ-kcuFLUnpe2xVovIuqXzrd2TB_79BkWx-Lj92aKJhxyWCWeobsRKCLt1Sjcxg5TRNzbqNKiId3g6a6OTapRlZQ3ya0auTWyNPuxmN0skaNBVGLK3fnX6B2tlMD7r0CX_s0AvRpHeUkxHd0jd7NFSQ9GFrhPboT-AbkzuuPomGX0kPx8H7pUCoJGg48uLyLb9fTU_EaYBGoGaijiFq8u6LAdUqCLXQV6FnfDnDhJU8UcGmdKlwdfluXh-ltZ0ymSq39Ejo8-fD1clLm0QumgVpvS122jMKqwMp5xBT44i8LdWdYpy4IxEoRXxgourQltxxwSrxVO-Kr2gT8me_26D08JdbGLMg23TrWiNdwCqAokWOWYlVwVREy_VruMO47lL1a6yvCkE0U0UkRnihTkzTzsbATeuG7AO6Tb3Blxs1PD-vxEZzHUleemijYbICRy5ZytvRTCNpIZ0fEuTra9THW9SW6Tbqxxovk1E9ifWETnjWDQ0cJU-DkQBXk1v44ijPcypg_rbewj8ParbRgryJORo-ZVcI6pxQAFkTu8trPM3Tf9r9MEEy7R-AN49h9Lek5u4-Poctone5vzbXgRjbCNfZnE7A_75SWe priority: 102 providerName: Taylor & Francis |
Title | Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection |
URI | https://www.tandfonline.com/doi/abs/10.1080/22221751.2020.1858177 https://www.ncbi.nlm.nih.gov/pubmed/33251966 https://www.proquest.com/docview/2508726164 https://www.proquest.com/docview/2465759500 https://pubmed.ncbi.nlm.nih.gov/PMC7782266 https://doaj.org/article/1d3a1172619941ccb2d744b570a4f3f8 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Za9wwEB5yvBRKaXpumy4q9NWpbcmS_FBKTpZCQsl2y_alRpebwtab7gHdf1-NLC_ZkBL6YrAt2bJmxvNZnvkG4J223HJKXWIMNwnLLU10ibVemPcvtS11mz52fsEHI_ZpXIy3oCNUiBM4v_PTDutJjWaTgz-_Vx-9wX-IEXLvvYvzwLrAr73cH5KFzITYhl3vnATa6nlE_OHlLLwPDozf2CvBbl1ez7-utOGxArH_LVrTu8Dp7RjLG07r7DE8imiTHLbqsQdbrnkCD9ulOtJmID2F7yeuDmUiiAeDZLjyKtmQK_ULKRSImhNFkNN4siLz5TwEweiJI9f-TRmTKkmopkP8SMnw8HKYHE-_JjnporyaZzA6O_1yPEhi2YXE8FwuEpuXhcSIw0zZlEpundFo-LVOa6lTp5TgzEqlGRVaubJODQq2ZIbZLLeOPoedZtq4l0CMbyJVQbWRJSsV1ZzLjAuupUm1oLIHrJvaykROciyNMamySF3aSaRCiVRRIj04WHe7bkk57utwhHJbN0ZO7XBgOvtRRROtMktV5vEcR7rkzBidW8GYLkSqWE1rP9jyptSrRVhSqdv6JxW9ZwD7nYpUnY5XHn1KvB1nPXi7Pu3NG__ZqMZNl74Nwz9jZZGmPXjRatT6KSjFtGPOeyA2dG3jMTfPND-vAoW4QGDI-av_ncjX8AB32zWofdhZzJbujUdlC92H7fTbwG_FWPRh9-j04vNlP6xw9IMF_gUqyC4R |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbhMx9KmkB5AQYidQwEhwHDoz9tieA0JdldI2Qk2LeqrxNhQpTEKTCOWn-Eb8ZglNheip17E9evZb_fwWgLfGcccp9ZG13EYsdTQyOfZ6YUG_FC43dfrYYZ_3Ttin0-x0BX63uTAYVtnKxEpQu5FFH_l6UNVSBHOfs4_jnxF2jcLX1baFRk0W-37-K1zZJh_2tgN-36Xp7s7xVi9qugpElqdyGrk0zyQG1CXaxVRy561Bui5MXEgTe60FZ05qw6gw2udFbBHunFnmktR5Gv57C1YZDVeZDqxu7vQ_Hy28OoGBOEtYmyok4_Wgf4PVn-FVNA2fZCYTIZaUYNUr4Eql1H_Zu1fDNi_pwd37cK8xYMlGTXEPYMWXD-Fu7f0jdVLTIzjb9kXVeYIE-5IM5oHKS3Kuf2BVBqInRBMskzyck8lsUsXVmKEn4yB8mzxNUjXoIQFSMtg4GkRboy9RStrAsfIxnNzImT-BTjkq_TMgNkyROqPGypzlmhrOZcIFN9LGRlDZBdYerbJNmXPstjFUSVMNtcWIQoyoBiNdeL9YNq7rfFy3YBPxtpiMZbqrD6OLb6rhepU4qpMEyTYPe7fWpE4wZjIRa1bQIgCbX8a6mlZemqJuqaLoNQCstSSiGrkzUX-5pAtvFsNBYuAzkC79aBbmMHxsy7M47sLTmqIWu6AUM5k574JYorWlbS6PlN_Pq6rkAm1Nzp__H6zXcLt3fHigDvb6-y_gDm6odmitQWd6MfMvg4k3Na8aviLw9aZZ-Q_pxl8A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSAgJofIqgRaMxDUQx47tHEvb1fKqEEsRXLD8pEhLdtXsHvrv8SRO1K2oeuDqh2JnZjzj8cw3CL0yjjtOqc-t5TZnpaO5qaHWC4v6Jbja9Oljn4759IS9_14N0YRtCquEO3TogSK6sxqEe-nCEBH3Jqq0aEhXcLsrY5OsJBHiJrpVyajrI0sXP6ajmyVyNGeEDbk7V83e0EodeP8l6NJ_GaCX4ygvKKbJNrqXLEq837PAfXTDNw_Q3d4dh_sso4fo56EPXSkIHA0-PDuPbNfgU_0HYBKwbrHGgFs8P8ftuu0CXczc42U8DVPiJO4q5uC4Ujzb_zLLDxbf8hIPkVzNI3QyOfp6MM1TaYXc8lKuclfWlYSoQqJdQSV33hoQ7mCKIE3htRacOakNo8JoX4fCAvFqZpkjpfP0MdpqFo1_grCNQ6SuqLGyZrWmhnNJuOBG2sIIKjPEhl-rbMIdh_IXc0USPOlAEQUUUYkiGXo9Tlv2wBvXTXgLdBsHA25217A4-6WSGCriqCbRZuMAiUysNaUTjJlKFJoFGuJi64tUV6vObRL6GieKXrOA3YFFVDoIWhUtTAmf4yxDL8fuKMLwLqMbv1jHMQxev-qqKDK003PUuAtKIbWY8wyJDV7b2OZmT_P7tIMJF2D8cf70P7b0At3-fDhRH98df3iG7kBP733aRVurs7Xfi_bYyjzvJO4vB10oRA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Defining+the+Syrian+hamster+as+a+highly+susceptible+preclinical+model+for+SARS-CoV-2+infection&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Rosenke%2C+Kyle&rft.au=Meade-White%2C+Kimberly&rft.au=Letko%2C+Michael&rft.au=Clancy%2C+Chad&rft.date=2020-01-01&rft.issn=2222-1751&rft.eissn=2222-1751&rft.volume=9&rft.issue=1&rft.spage=2673&rft.epage=2684&rft_id=info:doi/10.1080%2F22221751.2020.1858177&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_22221751_2020_1858177 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon |